Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|January 1, 1984
Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in salineM L Slevin, V J Harvey, G W Aherne, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1985
Variable bioavailability following repeated oral doses of etoposideV J Harvey, M L Slevin, S P Joel, et al.
British Journal of Clinical Pharmacology|October 1, 1981
The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemiaM L Slevin, E M Piall, G W Aherne, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1986
A phase II study of tamoxifen in ovarian cancerM L Slevin, V J Harvey, R J Osborne, et al.
British Journal of Cancer|March 1, 1993
Patient compliance with prolonged low-dose oral etoposide for small cell lung cancerC R Lee, P W Nicholson, R L Souhami, et al.
British Journal of Cancer|July 17, 1999
An analysis of first-time enquirers to the CancerBACUP information service: variations with cancer site, demographic status and geographical locationM Boudioni, K McPherson, J Mossman, et al.
British Journal of Cancer|December 1, 1990
Phase II trial of UFT in advanced colorectal and gastric cancerS T Malik, D Talbot, P I Clarke, et al.
Nuclear Medicine Communications|March 1, 1989
Therapeutic considerations in the use of intraperitoneal radiolabelled monoclonal antibodies in ovarian carcinomaM E Crowther, B G Ward, M Granowska, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observationM L Slevin, S P Joel, R Whomsley, et al.
BMJ (Clinical Research Ed.)|June 2, 1990
Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general publicM L Slevin, L Stubbs, H J Plant, et al.
Pageof 10